Gastroenterology
Volume 138, Issue 5 , Pages 1714-1726.e13 , May 2010

Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer

  • Nuh N. Rahbari

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • ,
  • Maximilian Aigner

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • ,
  • Kristian Thorlund

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
    • ,
  • Nathan Mollberg

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • ,
  • Edith Motschall

      Affiliations

    • Institute of Medical Biometry and Medical Informatics, University of Freiburg, Germany
    • ,
  • Katrin Jensen

      Affiliations

    • Institute of Medical Biometry and Informatics, University of Heidelberg, Germany
    • ,
  • Markus K. Diener

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • ,
  • Markus W. Büchler

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • ,
  • Moritz Koch

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • ,
  • Jürgen Weitz

      Affiliations

    • Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Germany
    • Corresponding Author InformationReprint requests Address requests for reprints to: Jürgen Weitz, MD, MSc, Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120. fax: (49) 6221 56 5506

Received 25 April 2009 ,Accepted 11 January 2010.

References 

  1. Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J. 1869;14:146–149
  2. Engell HC. Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl. 1955;201:1–70
  3. Riethdorf S, Wikman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer. 2008;123:1991–2006
  4. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353:793–802
  5. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834
  6. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16
  7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  8. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. London, United Kingdom: The Cochrane Collaboration; 2009;
  9. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326:219
  10. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  11. Hardingham JE, Kotasek D, Sage RE, et al. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med. 1995;1:789–794
  12. Hardingham JE, Hewett PJ, Sage RE, et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer. 2000;89:8–13
  13. Bessa X, Elizalde JI, Boix L, et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology. 2001;120:1084–1092
  14. Ito S, Nakanishi H, Hirai T, et al. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett. 2002;183:195–203
  15. Bessa X, Pinol V, Castellvi-Bel S, et al. Prognostic value of postoperative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure. Ann Surg. 2003;237:368–375
  16. Giacomelli L, Gianni W, Belfiore C, et al. Persistence of epidermal growth factor receptor and interleukin 10 in blood of colorectal cancer patients after surgery identifies patients with high risk to relapse. Clin Cancer Res. 2003;9:2678–2682
  17. Chen WS, Chung MY, Liu JH, et al. Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg. 2004;28:552–557
  18. Douard R, Wind P, Sales JP, et al. Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay. Surgery. 2006;139:556–562
  19. Katsumata K, Sumi T, Mori Y, et al. Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR. Int J Clin Oncol. 2006;11:385–389
  20. Koch M, Kienle P, Kastrati D, et al. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer. Int J Cancer. 2006;118:3072–3077
  21. Lloyd JM, McIver CM, Stephenson SA, et al. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res. 2006;12:417–423
  22. Allen-Mersh TG, McCullough TK, Patel H, et al. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg. 2007;94:96–105
  23. Friederichs J, Gertler R, Rosenberg R, et al. Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma. World J Surg. 2007;31:2329–2334
  24. Koch M, Antolovic D, Kienle P, et al. Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer. Int J Colorectal Dis. 2007;22:359–365
  25. Sadahiro S, Suzuki T, Maeda Y, et al. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. Ann Surg Oncol. 2007;14:1092–1098
  26. Koyanagi K, Bilchik AJ, Saha S, et al. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res. 2008;14:7391–7396
  27. Uen YH, Lu CY, Tsai HL, et al. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol. 2008;15:2120–2128
  28. Yie SM, Lou B, Ye SR, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol. 2008;15:3073–3082
  29. Wong SC, Chan CM, Ma BB, et al. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res. 2009;15:1005–1012
  30. Nakamori S, Kameyama M, Furukawa H, et al. Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum. 1997;40(suppl):S29–S36
  31. Iinuma H, Okinaga K, Adachi M, et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J Cancer. 2000;89:337–34420
  32. Akashi A, Komuta K, Haraguchi M, et al. Carcinoembryonic antigen mRNA in the mesenteric vein is not a predictor of hepatic metastasis in patients with resectable colorectal cancer: a long-term study. Dis Colon Rectum. 2003;46:1653–1658
  33. Sunouchi K, Machinami R, Mori M, et al. Clinical impact of carcinoembryonic antigen messenger ribonucleic acid expression in tumor-draining vein blood on postoperative liver metastasis in patients with colorectal carcinoma: a prospective, cohort study. Dis Colon Rectum. 2003;46:467–473
  34. Schlimok G, Funke I, Bock B, et al. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol. 1990;8:831–837
  35. Lindemann F, Schlimok G, Dirschedl P, et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet. 1992;340:685–68919
  36. Schott A, Vogel I, Krueger U, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg. 1998;227:372–379
  37. Vogel I, Soeth E, Kalthoff H, et al. Prognostic impact of disseminated tumor cells detected by CK20 RT-PCR in patients with colorectal and gastric carcinoma. Langenbecks Arch Surg (Forumband). 1999;116:701–706
  38. Leinung S, Wurl P, Schonfelder A, et al. Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis. J Hematother Stem Cell Res. 2000;9:905–911
  39. Steinert R, Hantschick M, Vieth M, et al. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer. Arch Surg. 2008;143:122–128
  40. Taniguchi T, Makino M, Suzuki K, et al. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer. 2000;89:970–976
  41. Yamaguchi K, Takagi Y, Aoki S, et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg. 2000;232:58–65
  42. Etoh T, Ueo H, Inoue H, et al. Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma. Ann Surg Oncol. 2001;8:407–412
  43. Fujita S, Kudo N, Akasu T, et al. Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosis. Int J Colorectal Dis. 2001;16:141–146
  44. Guller U, Zajac P, Schnider A, et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg. 2002;236:768–775
  45. Sadahiro S, Suzuki T, Ishikawa K, et al. Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer. Ann Surg Oncol. 2005;12:988–994
  46. Iinuma H, Okinaga K, Egami H, et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol. 2006;28:297–306
  47. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329–340
  48. Pierga JY, Bonneton C, Vincent-Salomon A, et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res. 2004;10:1392–1400
  49. Wiedswang G, Borgen E, Schirmer C, et al. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer. 2006;118:2013–2019
  50. Soeth E, Vogel I, Roder C, et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res. 1997;57:3106–3110
  51. Weitz J, Kienle P, Lacroix J, et al. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res. 1998;4:343–348
  52. Vincent-Salomon A, Bidard FC, Pierga JY. Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues. J Clin Pathol. 2008;61:570–576
  53. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 1996;347:649–653
  54. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. APMIS. 2008;116:754–770
  55. Alix-Panabieres C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res. 2008;14:5013–5021
  56. Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst. 1970;45:773–782
  57. Schlimok G, Riethmuller G. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol. 1990;1:207–215
  58. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448–456
  59. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A. 2003;100:7737–7742
  60. Stoecklein NH, Hosch SB, Bezler M, et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell. 2008;13:441–453
  61. Lugo TG, Braun S, Cote RJ, et al. Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol. 2003;21:2609–2615
    Appendix 3. Assessment of risk of bias
  1. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration; 2009;
  2. Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:iii–173
  3. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;19:328;1490
  4. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926
  5. Schünemann H, Brozek J, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009] The GRADE Working Group; 2009;
    Appendix 4. Assessment of Publication Bias
  1. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  1. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101–105
    Appendix 6. Legends to Tables
  1. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration; 2009;

 Conflicts of interest The authors disclose no conflicts.

 Funding This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant number WE 3548/4-1.

PII: S0016-5085(10)00045-4

doi: 10.1053/j.gastro.2010.01.008

Gastroenterology
Volume 138, Issue 5 , Pages 1714-1726.e13 , May 2010

Article Tools

* Image Usage & Resolution